These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29559554)

  • 1. Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.
    Herborg F; Andreassen TF; Berlin F; Loland CJ; Gether U
    J Biol Chem; 2018 May; 293(19):7250-7262. PubMed ID: 29559554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.
    Hansen FH; Skjørringe T; Yasmeen S; Arends NV; Sahai MA; Erreger K; Andreassen TF; Holy M; Hamilton PJ; Neergheen V; Karlsborg M; Newman AH; Pope S; Heales SJ; Friberg L; Law I; Pinborg LH; Sitte HH; Loland C; Shi L; Weinstein H; Galli A; Hjermind LE; Møller LB; Gether U
    J Clin Invest; 2014 Jul; 124(7):3107-20. PubMed ID: 24911152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Quantum Dot Imaging Reveals PKCβ-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant.
    Thal LB; Tomlinson ID; Quinlan MA; Kovtun O; Blakely RD; Rosenthal SJ
    ACS Chem Neurosci; 2019 Jan; 10(1):460-471. PubMed ID: 30153408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-quantum-dot tracking reveals altered membrane dynamics of an attention-deficit/hyperactivity-disorder-derived dopamine transporter coding variant.
    Kovtun O; Sakrikar D; Tomlinson ID; Chang JC; Arzeta-Ferrer X; Blakely RD; Rosenthal SJ
    ACS Chem Neurosci; 2015 Apr; 6(4):526-34. PubMed ID: 25747272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D
    Gowrishankar R; Gresch PJ; Davis GL; Katamish RM; Riele JR; Stewart AM; Vaughan RA; Hahn MK; Blakely RD
    J Neurosci; 2018 Jun; 38(23):5302-5312. PubMed ID: 29739866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors.
    DiCarlo GE; Aguilar JI; Matthies HJ; Harrison FE; Bundschuh KE; West A; Hashemi P; Herborg F; Rickhag M; Chen H; Gether U; Wallace MT; Galli A
    J Clin Invest; 2019 May; 129(8):3407-3419. PubMed ID: 31094705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Action of Zn2+ on the Transport Cycle of the Dopamine Transporter.
    Li Y; Hasenhuetl PS; Schicker K; Sitte HH; Freissmuth M; Sandtner W
    J Biol Chem; 2015 Dec; 290(52):31069-76. PubMed ID: 26504078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder.
    Mazei-Robison MS; Couch RS; Shelton RC; Stein MA; Blakely RD
    Neuropharmacology; 2005 Nov; 49(6):724-36. PubMed ID: 16171832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder.
    Mereu M; Contarini G; Buonaguro EF; Latte G; Managò F; Iasevoli F; de Bartolomeis A; Papaleo F
    Neuropharmacology; 2017 Jul; 121():179-194. PubMed ID: 28454982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.
    Sakrikar D; Mazei-Robison MS; Mergy MA; Richtand NW; Han Q; Hamilton PJ; Bowton E; Galli A; Veenstra-Vanderweele J; Gill M; Blakely RD
    J Neurosci; 2012 Apr; 32(16):5385-97. PubMed ID: 22514303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression.
    Horschitz S; Hummerich R; Lau T; Rietschel M; Schloss P
    Mol Psychiatry; 2005 Dec; 10(12):1104-9. PubMed ID: 16103889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADHD and the dopamine transporter: are there reasons to pay attention?
    Mazei-Robinson MS; Blakely RD
    Handb Exp Pharmacol; 2006; (175):373-415. PubMed ID: 16722244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ack1 is a dopamine transporter endocytic brake that rescues a trafficking-dysregulated ADHD coding variant.
    Wu S; Bellve KD; Fogarty KE; Melikian HE
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15480-5. PubMed ID: 26621748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations.
    Vandenbergh DJ; Thompson MD; Cook EH; Bendahhou E; Nguyen T; Krasowski MD; Zarrabian D; Comings D; Sellers EM; Tyndale RF; George SR; O'Dowd BF; Uhl GR
    Mol Psychiatry; 2000 May; 5(3):283-92. PubMed ID: 10889531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.
    Mergy MA; Gowrishankar R; Gresch PJ; Gantz SC; Williams J; Davis GL; Wheeler CA; Stanwood GD; Hahn MK; Blakely RD
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4779-88. PubMed ID: 25331903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model.
    Dai H; Jackson CR; Davis GL; Blakely RD; McMahon DG
    J Neurodev Disord; 2017 Dec; 9(1):38. PubMed ID: 29281965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder.
    Hamilton PJ; Campbell NG; Sharma S; Erreger K; Herborg Hansen F; Saunders C; Belovich AN; ; Sahai MA; Cook EH; Gether U; McHaourab HS; Matthies HJ; Sutcliffe JS; Galli A
    Mol Psychiatry; 2013 Dec; 18(12):1315-23. PubMed ID: 23979605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.
    Bowton E; Saunders C; Reddy IA; Campbell NG; Hamilton PJ; Henry LK; Coon H; Sakrikar D; Veenstra-VanderWeele JM; Blakely RD; Sutcliffe J; Matthies HJ; Erreger K; Galli A
    Transl Psychiatry; 2014 Oct; 4(10):e464. PubMed ID: 25313507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine transporter and attention-deficit/hyperactivity disorder.
    Madras BK; Miller GM; Fischman AJ
    Biol Psychiatry; 2005 Jun; 57(11):1397-409. PubMed ID: 15950014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T; Rohde LA; Hutz MH
    Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.